Literature DB >> 22296358

Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: cholangiocarcinoma.

Supot Kamsa-ard1, Surapon Wiangnon, Krittika Suwanrungruang, Supannee Promthet, Narong Khuntikeo, Siriporn Kamsa-ard, Suwannee Mahaweerawat.   

Abstract

BACKGROUND: The Khon Kaen Cancer Registry (KKCR), having both hospital and population-based registration, was established in 1984 at the Faculty of Medicine, Khon Kaen University. Liver cancer is the most frequent malignancy among Thais from northeastern Thailand, but there has hitherto been no assessment of trends over time.
OBJECTIVE: To perform a statistical assessment of the incidence trends between 1985 and 2009 of liver cancer, specifically focusing on cholangiocarcinoma (CHCA).
METHODS: Cases of CHCA, registered between 1985 and 2009, were retrieved from the KKCR and all those with a specific ICD-O-3rd diagnosis with a coding of C22.1, C24.0, C24.8 and C24.9 were selected. Incidence trends were calculated using the generalized linear model method (GLM), which generates incidence rate based logarithms. Jointpoint analysis was used to identify the best fitting model.
RESULTS: Of the 18,589 cases of liver cancer 42% (7,859) were hepatocellular carcinoma and 58% (10,731) were CHCA. Among persons with CHCA, males were affected two times more frequently than females. Three-quarters of the cases were between 55 and 69 years of age. Morphology verified through a cytological or histological examination of tissue from the primary site (%MV) was only 10.8 % (1,141). The respective overall Age Standardized Rate (ASR) for CHCA from 1985 to 2009 was 16.8 to 62.0 per 100,000 among males and 4.8 to 25.6 per 100,000 among females. The respective, overall, ASR of CHCA among males vs. females was 44.3 per 100,000 (95% CI: 38.9 to 49.7) vs. 17.6 (95% CI: 14.5 to 20.7). Among males vs. females, the respective incidence from 1990 to 2009 has been significantly decreasing by -0.7% per year (Annual Percent Change, APC: -0.7%, 95%CI: -2.1% to +0.8%) vs. -0.4% per year (APC: -0.4%, 95% CI: -2.1% to +1.4%).
CONCLUSIONS: The rate increase in the first 5 to 6 years may be due to improved completeness of the registry, since in the subsequent 10 to 12 years there is a rather stable rate. It may be, however, that the recent decline in incidence represents a real fall in risk.

Entities:  

Mesh:

Year:  2011        PMID: 22296358

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  15 in total

1.  Viable metacercariae of Opisthorchis viverrini in northeastern Thai cyprinid fish dishes--as part of a rational program for control of O. viverrini-associated cholangiocarcinoma.

Authors:  Jiraporn Prasongwatana; Porntip Laummaunwai; Thidarut Boonmars; Somchai Pinlaor
Journal:  Parasitol Res       Date:  2012-10-05       Impact factor: 2.289

2.  Repression of Nrf2 enhances antitumor effect of 5-fluorouracil and gemcitabine on cholangiocarcinoma cells.

Authors:  Papavee Samatiwat; Auemduan Prawan; Laddawan Senggunprai; Veerapol Kukongviriyapan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-02-24       Impact factor: 3.000

3.  Annexin A1: A new immunohistological marker of cholangiocarcinoma.

Authors:  Nuttanan Hongsrichan; Rucksak Rucksaken; Yaovalux Chamgramol; Porntip Pinlaor; Anchalee Techasen; Puangrat Yongvanit; Narong Khuntikeo; Chawalit Pairojkul; Somchai Pinlaor
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

4.  Toward integrated opisthorchiasis control in northeast Thailand: the Lawa project.

Authors:  Banchob Sripa; Sirikachorn Tangkawattana; Thewarach Laha; Sasithorn Kaewkes; Frank F Mallory; John F Smith; Bruce A Wilcox
Journal:  Acta Trop       Date:  2014-08-04       Impact factor: 3.112

5.  Influence of Water Irrigation Schemes and Seasonality on Transmission Dynamics of Opisthorchis viverrini in the Snail Intermediate Host, Bithynia siamensis goniomphalos in Rice Paddy Fields in Northeast Thailand.

Authors:  Kulthida Kopolrat; Paiboon Sithithaworn; Nadda Kiatsopit; Jutamas Namsanor; Nonglak Laoprom; Smarn Tesana; Ross H Andrews; Trevor N Petney
Journal:  Am J Trop Med Hyg       Date:  2020-05-07       Impact factor: 2.345

6.  Plasma autoantibodies against heat shock protein 70, enolase 1 and ribonuclease/angiogenin inhibitor 1 as potential biomarkers for cholangiocarcinoma.

Authors:  Rucksak Rucksaken; Chawalit Pairojkul; Porntip Pinlaor; Narong Khuntikeo; Sittiruk Roytrakul; Carlo Selmi; Somchai Pinlaor
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

7.  Aberrant expression of NF-κB in liver fluke associated cholangiocarcinoma: implications for targeted therapy.

Authors:  Wunchana Seubwai; Chaisiri Wongkham; Anucha Puapairoj; Narong Khuntikeo; Ake Pugkhem; Chariya Hahnvajanawong; Jariya Chaiyagool; Kazuo Umezawa; Seiji Okada; Sopit Wongkham
Journal:  PLoS One       Date:  2014-08-29       Impact factor: 3.240

8.  Health-Related Quality of Life and Survival of Cholangiocarcinoma Patients in Northeastern Region of Thailand.

Authors:  Somkiattiyos Woradet; Nopparat Songserm; Supannee Promthet; Donald Maxwell Parkin
Journal:  PLoS One       Date:  2016-09-29       Impact factor: 3.240

9.  A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand.

Authors:  Narong Khuntikeo; Watcharin Loilome; Bandit Thinkhamrop; Nittaya Chamadol; Puangrat Yongvanit
Journal:  PLoS Negl Trop Dis       Date:  2016-01-21

10.  Estimation of the Incidence of Hepatocellular Carcinoma and Cholangiocarcinoma in Songkhla, Thailand, 1989-2013, Using Multiple Imputation Method.

Authors:  Seesai Yeesoonsang; Surichai Bilheem; Edward McNeil; Sophon Iamsirithaworn; Chuleeporn Jiraphongsa; Hutcha Sriplung
Journal:  Cancer Res Treat       Date:  2016-05-18       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.